Altium Capital Management LLC 13D and 13G filings for Regulus Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 2:30 pm Sale | 2021-12-31 | 13G | Regulus Therapeutics Inc. RGLS | Altium Capital Management LLC | 172,978 2.100% | -150,000 (-46.44%) | Filing |
| 2021-02-12 5:11 pm Unchanged | 2020-12-31 | 13G | Regulus Therapeutics Inc. RGLS | Altium Capital Management LLC | 322,978 6.800% | 0 (Unchanged) | Filing |